healthprotocol.wiki
Protocols
Evidence
Outcomes
Home
/
Evidence
van-besien_2016_cohort_reduced-intensity-haplo-plus-single-cord-transplant-compared-to-double-cord-transplant-improved-engraftment-and-graft-versus-host-disease-free-relapse-free-survival
20 findings
Protocol
therapy-stem-cell-transplant-double-umbilical-cord-blood-reduced-intensity-conditioning-fludarabine-cyclophosphamide-low-dose-total-body-irradiation
Outcome
acute-graft-versus-host-disease-grade-ii-iv-cumulative-incidence
n
193
effect
-70
attribution
60
Protocol
therapy-stem-cell-transplant-haplo-cord-reduced-intensity-conditioning-fludarabine-melphalan-anti-thymocyte-globulin
Outcome
acute-graft-versus-host-disease-grade-ii-iv-cumulative-incidence
n
97
effect
70
attribution
60
Protocol
therapy-stem-cell-transplant-double-umbilical-cord-blood-reduced-intensity-conditioning-fludarabine-cyclophosphamide-low-dose-total-body-irradiation
Outcome
acute-graft-versus-host-disease-grade-iii-iv-cumulative-incidence
n
193
effect
-75
attribution
60
Protocol
therapy-stem-cell-transplant-haplo-cord-reduced-intensity-conditioning-fludarabine-melphalan-anti-thymocyte-globulin
Outcome
acute-graft-versus-host-disease-grade-iii-iv-cumulative-incidence
n
97
effect
75
attribution
60
Protocol
therapy-stem-cell-transplant-double-umbilical-cord-blood-reduced-intensity-conditioning-fludarabine-cyclophosphamide-low-dose-total-body-irradiation
Outcome
chronic-graft-versus-host-disease-cumulative-incidence
n
189
effect
-90
attribution
65
Protocol
therapy-stem-cell-transplant-haplo-cord-reduced-intensity-conditioning-fludarabine-melphalan-anti-thymocyte-globulin
Outcome
chronic-graft-versus-host-disease-cumulative-incidence
n
97
effect
90
attribution
65
Protocol
therapy-stem-cell-transplant-double-umbilical-cord-blood-reduced-intensity-conditioning-fludarabine-cyclophosphamide-low-dose-total-body-irradiation
Outcome
hematology-time-to-neutrophil-engraftment-anc-500-per-microliter
n
193
effect
-30
attribution
55
Protocol
therapy-stem-cell-transplant-haplo-cord-reduced-intensity-conditioning-fludarabine-melphalan-anti-thymocyte-globulin
Outcome
hematology-time-to-neutrophil-engraftment-anc-500-per-microliter
n
97
effect
30
attribution
55
Protocol
therapy-stem-cell-transplant-double-umbilical-cord-blood-reduced-intensity-conditioning-fludarabine-cyclophosphamide-low-dose-total-body-irradiation
Outcome
hematology-time-to-platelet-engraftment-20k-per-microliter
n
190
effect
-60
attribution
60
Protocol
therapy-stem-cell-transplant-haplo-cord-reduced-intensity-conditioning-fludarabine-melphalan-anti-thymocyte-globulin
Outcome
hematology-time-to-platelet-engraftment-20k-per-microliter
n
97
effect
60
attribution
60
Protocol
therapy-stem-cell-transplant-double-umbilical-cord-blood-reduced-intensity-conditioning-fludarabine-cyclophosphamide-low-dose-total-body-irradiation
Outcome
oncology-relapse-cumulative-incidence
n
193
effect
-40
attribution
55
Protocol
therapy-stem-cell-transplant-haplo-cord-reduced-intensity-conditioning-fludarabine-melphalan-anti-thymocyte-globulin
Outcome
oncology-relapse-cumulative-incidence
n
97
effect
40
attribution
55
Protocol
therapy-stem-cell-transplant-double-umbilical-cord-blood-reduced-intensity-conditioning-fludarabine-cyclophosphamide-low-dose-total-body-irradiation
Outcome
survival-graft-versus-host-disease-free-relapse-free-probability
n
187
effect
-30
attribution
55
Protocol
therapy-stem-cell-transplant-haplo-cord-reduced-intensity-conditioning-fludarabine-melphalan-anti-thymocyte-globulin
Outcome
survival-graft-versus-host-disease-free-relapse-free-probability
n
97
effect
30
attribution
55
Protocol
therapy-stem-cell-transplant-double-umbilical-cord-blood-reduced-intensity-conditioning-fludarabine-cyclophosphamide-low-dose-total-body-irradiation
Outcome
survival-overall-probability
n
193
effect
0
attribution
50
Protocol
therapy-stem-cell-transplant-haplo-cord-reduced-intensity-conditioning-fludarabine-melphalan-anti-thymocyte-globulin
Outcome
survival-overall-probability
n
97
effect
0
attribution
50
Protocol
therapy-stem-cell-transplant-double-umbilical-cord-blood-reduced-intensity-conditioning-fludarabine-cyclophosphamide-low-dose-total-body-irradiation
Outcome
survival-progression-free-probability
n
193
effect
-15
attribution
45
Protocol
therapy-stem-cell-transplant-haplo-cord-reduced-intensity-conditioning-fludarabine-melphalan-anti-thymocyte-globulin
Outcome
survival-progression-free-probability
n
97
effect
15
attribution
45
Protocol
therapy-stem-cell-transplant-double-umbilical-cord-blood-reduced-intensity-conditioning-fludarabine-cyclophosphamide-low-dose-total-body-irradiation
Outcome
survival-treatment-related-mortality-cumulative-incidence
n
193
effect
10
attribution
40
Protocol
therapy-stem-cell-transplant-haplo-cord-reduced-intensity-conditioning-fludarabine-melphalan-anti-thymocyte-globulin
Outcome
survival-treatment-related-mortality-cumulative-incidence
n
97
effect
-10
attribution
40